MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hallucinations"

  • MDS Virtual Congress 2020

    Visual Hallucinations and Illusions in Parkinson’s Disease: The Role of Ocular Pathology

    A. Marques, S. Beze, B. Pereira, C. Chassain, N. Monneyron, L. Delaby, C. Lambert, P. Derost, B. Debilly, I. Rieu, S.G Lewis, F. Chiambaretta, F. Durif (Clermont-Ferrand, France)

    Objective: To determine whether different mechanisms could lead to the emergence of visual hallucinations (VH) (defined as false perceptions with no external stimulus) versus illusions…
  • MDS Virtual Congress 2020

    Approach to the patients with the hallucinations, in the Parkinson’s disease in the low-income country and environment of restricted medications and stigmas

    B. Mukhammedaminov (Tashkent, Uzbekistan)

    Objective: Expose the percentage of patients with hallucinations in studying group of Parkinson’s disease patients in Uzbekistan. Background: Uzbekistan has 35 million population, largest in…
  • MDS Virtual Congress 2020

    Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus

    H. Bejr-kasem, J. Pagonabarraga, F. Sampedro, S. Martínez-Horta, R. Perez-Gonzalez, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, A. Campolongo, C. Izquierdo, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…
  • 2019 International Congress

    A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment

    K. Amodeo (Rochester, NY, USA)

    Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…
  • 2019 International Congress

    Cognitive dysfunction in patients with Parkinson’s disease and psychosis

    A. Lenka, S. Hegde, S. Arumugham, R. Yadav, P. Pal (Washington, DC, USA)

    Objective: The objective of this study was to explore the pattern of cognitive dysfunction in the patient's with Parkinson's disease and psychosis (PD-P) by comparing…
  • 2019 International Congress

    The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

    A. Powell, J. Shine, S. Lewis (Sydney, Australia)

    Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
  • 2019 International Congress

    Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

    B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

    Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…
  • 2019 International Congress

    Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

    E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…
  • 2019 International Congress

    Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

    A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

    Objective: To test whether increased reliance on prior knowledge is associated with visual hallucinations in Lewy Body Disease (LBD: Parkinson’s disease and Dementia with Lewy…
  • 2019 International Congress

    Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

    O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)

    Objective: To assess the daily variability of visual and autonomic nervous system (ANS) functions in relation to sleep disorders to determine circadian PD phenotypes Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley